Nathan Hobbs

Nathan Hobbs is a seasoned professional in analytical chemistry, currently serving as a Senior Manager at Navire Pharma, CoA Therapeutics, and Orfan Biotech (now Cantero Therapeutics), all since 2021. Prior to these roles, Nathan held the position of Manager, CMC at Puma Biotechnology, Inc., where oversight of drug product production, stability testing, and regulatory filing contributions were key responsibilities from 2019 to 2021. Nathan's earlier experience includes roles at Applied Molecular Transport as a Senior Specialist in Analytical and QC, and as a Senior Research Associate at Achaogen, where contributions to regulatory submissions and analytical reference standards programs were prominent. Nathan began a career in research as an Associate at Gilead Sciences from 2011 to 2014 after earning a Bachelor of Science degree in Chemistry from Stanford University.